Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Syndax Pharmaceuticals granted stock options to purchase 66,700 shares to four new employees. The awards were issued under the company's 2023 Inducement Plan to comply with NASDAQ Listing Rule 5635(c)(4).
Key figures
- New employees
- 4
- Shares granted
- 66700
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.